News & Notes
- New Seminar - VC101: A Primer on Venture Capital; Sign-up Now ... View More
- Technology Transfer Contributes Multiple Benefits to Universities, Study Co-authored by Emory OTT's Sherer ... View More
- Emory featured in Tech Transfer Tactics: TTOs Add Online Video to Their Marketing Mix ... View More
- Emory featured in Tech Transfer Tactics: Supreme Court Shifts the Patent Landscape for Software, Other Business Methods ... View More
- Emory Licensee: Agilent Technologies Introduces New Exome Optimized for Clinical Research Sequencing ... View More
- Emory Start-up: Clearside Biomedical raises $6M, preps for Phase III trial ... View More
- Emory Start-up: Cambium Medical Technologies signs collaboration agreement with Gwowei Technology Company ... View More
- Emory Startup: Velocity Medical Solutions is Excited to Announce an Acquisition by Varian Medical Systems ... View More
- Emory Startup: AKESOgen and VA Million Veteran Program Collaborate to Genotype 105,000 Veterans ... View More
- Emory Licensee: Baxter Submits BLA For Approval of OBI-1 For Patients With Acquired Hemophilia A ... View More
The Incredible Potential of the Nanoparticle
Lily Yang, PhD
Just before cancer researcher Lily Yang received her medical degree from West China University in 1983, she saw a patient hospitalized with pancreatic cancer. Surgery wasn’t helpful and the patient was in severe pain, which Yang tried to combat with pain meds. After a few long nights, the patient died. "That's when I realized I wanted to be a researcher," Yang says, on an early spring day in her office at Winship Cancer Institute, which overlooks the CHOA heliport. "I wanted to fight cancer on a different level, not watch people suffer like that."
After earning a PhD in molecular and cell biology and biochemistry at Brown University and post doctoral training at University of South California, Yang came to Emory, where she is a professor of surgery and radiology and the Nancy Panoz Chair of Surgery in cancer research. As one of the most well funded researchers in the department, her goal is to apply nanotechnology to fight disease in the emerging field of nanomedicine.
Nanomedicine's secret weapon is its size, since it uses particles as small as antibodies or viruses to create molecular imaging probes and drug-carriers for in vivo delivery. Imaging with nanoparticles may help expose cancer before health has deteriorated, says Yang, and help guide surgeons in their efforts to detect, treat, and remove tumors.